BeStock  

Eton Pharmaceutical ETON

US equityMarket cap rank #2769Drug Manufacturers - Specialty & Generic
$60.85 −$0.51 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $60.85 0.00%
Open$61.00
Prev close$61.36
Day range$59.18 – $61.65
Volume562.7K
Market cap$1.76B
P/E (TTM)39.5
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$57.93M+157.9% YoY
Operating profit$23.01M+1,788.4% YoY
Net profit$35.25M+1,929.2% YoY
Diluted EPS$1.06+1,614.3% YoY
Free cash flow$32.00M+172.6% YoY
Operating cash flow$35.24M

Revenue, last 8 quarters

$11.6MDec '24$17.3MMar '25$18.9MJun '25$22.5MSep '25$21.3MDec '25$24.3MMar '26$37.6MJun '26$57.9MSep '26

Net profit, last 8 quarters

$-598.0KDec '24$-1.6MMar '25$-2.6MJun '25$-1.9MSep '25$1.5MDec '25$1.6MMar '26$11.6MJun '26$35.2MSep '26

Diluted EPS by quarter

-0.02Dec '24-0.06Mar '25-0.10Jun '25-0.07Sep '250.05Dec '250.05Mar '260.35Jun '261.06Sep '26

Free cash flow by quarter

$-8.9MDec '24$2.1MMar '25$8.0MJun '25$11.7MSep '25$-11.6MDec '25$-7.7MMar '26$7.3MJun '26$32.0MSep '26

Annual revenue

$39.0KFY20$21.8MFY21$21.3MFY22$31.6MFY23$39.0MFY24$80.0MFY25

Profitability & balance sheet

Gross margin69.2%
Operating margin28.8%
Net margin35.3%
Return on equity90.6%
Return on assets38.1%
Return on invested capital60.4%
Current ratio1.79
Liabilities / assets44.7%
Cash & investments$55.63M
Total debt$24.09M
Net cash (debt)$31.54M
Free cash flow / sales14.2%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $57.93M $37.59M $24.27M $79.95M $21.28M
Total Operating Revenue $57.93M $37.59M $24.27M $79.95M $21.28M
Cost of Revenue $13.62M $12.18M $9.53M $37.21M $8.18M
Gross Profit $44.30M $25.41M $14.74M $42.74M $13.10M
Operating Expense $21.29M $12.62M $12.32M $43.58M $10.64M
Selling and Admin Expenses $16.02M $11.63M $10.45M $35.82M $8.86M
-General & Admin Expense $16.02M $11.63M $10.45M $35.82M $8.86M
Research & Development $5.27M $993,000.00 $1.88M $7.77M $1.78M
Operating Profit $23.01M $12.79M $2.41M -$844,000.00 $2.46M
Net Non-Operating Interest Income (Expense) -$656,000.00 -$1.08M -$840,000.00 -$3.71M -$1.05M
Non-Operating Interest Expense $656,000.00 $1.08M $840,000.00 – –
Pretax Profit $22.36M $11.72M $1.57M -$4.56M $1.41M
Tax -$12.89M $140,000.00 $20,000.00 $43,000.00 -$69,000.00
Net Profit $35.25M $11.58M $1.55M -$4.60M $1.48M
Profit from Continuing Operations $35.25M $11.58M $1.55M -$4.60M $1.48M
Net Income to Parent Company $35.25M $11.58M $1.55M -$4.60M $1.48M
Net Income to Common Stockholders $35.25M $11.58M $1.55M -$4.60M $1.48M
Basic EPS $1.23 $0.42 $0.06 -$0.17 $0.06
Diluted EPS $1.06 $0.35 $0.05 -$0.17 $0.05
Total Other Finance Costs – – – $3.71M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $157.27M $115.81M $97.71M $92.11M $92.11M
Total Current Assets $96.78M $68.60M $53.25M $60.58M $60.58M
Cash and Cash Equivalents & Short-Term Investments $55.63M $26.85M $19.66M $25.94M $25.94M
-Cash and Cash Equivalents $55.63M $26.85M $19.66M $25.94M $25.94M
Receivables $26.43M $24.89M $13.41M $11.76M $11.76M
-Accounts Receivable $26.43M $24.89M $13.41M $11.76M $11.76M
Inventory $11.08M $10.14M $14.47M $15.42M $15.42M
Other Current Assets $3.65M $6.73M $5.71M $7.46M $7.46M
Total Non-Current Assets $60.49M $47.21M $44.47M $31.53M $31.53M
Net PPE $1.40M $1.47M $673,000.00 $636,000.00 $636,000.00
-Gross PPE $1.54M $1.47M $673,000.00 $1.12M $1.12M
-Accumulated Depreciation -$136,000.00 – – -$486,000.00 -$486,000.00
Goodwill and Other Intangible Assets $44.28M $45.68M $43.74M $30.88M $30.88M
Non-Current Deferred Assets $14.75M – – – –
Other Non-Current Assets $64,000.00 $64,000.00 $54,000.00 $19,000.00 $19,000.00
Total Liabilities $70.35M $69.22M $67.10M $65.96M $65.96M
Total Current Liabilities $54.10M $45.12M $44.18M $38.49M $38.49M
Payables $16.50M $14.41M $13.49M $10.98M $10.98M
-Accounts Payable $16.50M $14.41M $13.49M $10.98M $10.98M
Current Accrued Expenses $25.75M $21.89M $18.89M $18.73M $18.73M
Short-Term Debt and Capital Lease Obligation $11.84M $8.83M $11.81M $8.79M $8.79M
-Current Debt $11.84M $8.83M $11.81M $8.79M $8.79M
Total Non-Current Liabilities $16.26M $24.10M $22.92M $27.47M $27.47M
Long Term Debt and Capital Lease Obligation $12.24M $20.16M $19.38M $22.23M $22.23M
-Long Term Debt $11.23M $19.08M $18.94M $21.77M $21.77M
-Long Term Capital Lease Obligation $1.02M $1.08M $440,000.00 $460,000.00 $460,000.00
Other Non-Current Liabilities $4.01M $3.94M $3.54M $5.24M $5.24M
Total Equity $86.92M $46.59M $30.62M $26.15M $26.15M
Stockholders' Equity $86.92M $46.59M $30.62M $26.15M $26.15M
Capital Stock $29,000.00 $28,000.00 $27,000.00 $27,000.00 $27,000.00
-Common Stock $29,000.00 $28,000.00 $27,000.00 $27,000.00 $27,000.00
Additional Paid-In Capital $151.01M $145.92M $141.53M $138.62M $138.62M
Retained Earnings -$64.11M -$99.36M -$110.94M -$112.49M -$112.49M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $35.24M $7.26M $7.41M $10.52M -$11.55M
Net cash flow from continuing operations $35.24M $7.26M $7.41M $10.52M -$11.55M
Net Income from Continuing Operations $35.25M $11.58M $1.55M -$4.60M $1.48M
Depreciation & Depletion & Amortization $1.44M $1.39M $1.13M $4.04M $1.02M
Other Non-Cash Items $3.73M $839,000.00 $484,000.00 $5.83M $1.61M
Change in Working Capital $4.36M -$8.37M $2.49M -$859,000.00 -$17.04M
-Change in Receivables -$1.61M -$11.48M -$1.65M -$6.40M $1.33M
-Change in Inventory -$1.35M $3.32M $1.41M -$5.88M -$244,000.00
-Change in Prepaid Assets $3.08M -$1.02M $1.75M -$1.97M -$2.52M
-Change in Payables and Accrued Expense $5.53M $2.99M $2.80M $10.27M -$11.57M
-Change In Other Working Capital -$1.30M -$2.18M -$1.82M $3.11M -$4.03M
Net cash flow from investing -$3.24M $5,000.00 -$15.08M -$333,000.00 -$49,000.00
Net Cash Flow from Continuing Investing Activities -$3.24M $5,000.00 -$15.08M -$333,000.00 -$49,000.00
Net PPE Purchase and Sale -$13,000.00 $5,000.00 -$75,000.00 -$333,000.00 -$49,000.00
Net Intangibles Purchase and Sale -$3.23M $0.00 -$15.00M $0.00 $0.00
Financing Cash Flow -$3.22M -$76,000.00 $1.39M $815,000.00 $421,000.00
Net Cash Flow from Continuing Financing Activities -$3.22M -$76,000.00 $1.39M $815,000.00 $421,000.00
Net Issuance Payments Of Debt -$5.00M – – $0.00 $0.00
Proceeds from Stock Option Exercised $1.78M $2.92M $1.39M $815,000.00 $421,000.00
Ending Cash Balance $55.63M $26.85M $19.66M $25.94M $25.94M
Net Change in Cash $28.78M $7.18M -$6.28M $11.01M -$11.18M
Beginning Cash Balance $26.85M $19.66M $25.94M $14.94M $37.12M
Free Cash Flow $32.00M $7.26M -$7.67M $10.19M -$11.60M
Net Business Purchase and Sale – – – $0.00 –
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on ETON.

Sign in to join the discussion.

Scroll to Top